StockOtters
StockOttersSupply Chain Map
Livzon Pharmaceutical Group Inc. logo

Livzon Pharmaceutical Group Inc.

1513.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
1,536
Cost of Revenue
531
Gross Profit
1,005
Gross Margin
65.5%
Operating Income
370
Operating Margin
24.1%
Net Income
268
Net Margin
17.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
451
EBITDA Margin
29.4%

2023

12/31/2023

Revenue
1,616
Cost of Revenue
620
Gross Profit
995
Gross Margin
61.6%
Operating Income
314
Operating Margin
19.4%
Net Income
254
Net Margin
15.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
432
EBITDA Margin
26.8%

2022

12/31/2022

Revenue
1,642
Cost of Revenue
580
Gross Profit
1,062
Gross Margin
64.7%
Operating Income
306
Operating Margin
18.6%
Net Income
248
Net Margin
15.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
400
EBITDA Margin
24.4%

2021

12/31/2021

Revenue
1,568
Cost of Revenue
553
Gross Profit
1,015
Gross Margin
64.7%
Operating Income
295
Operating Margin
18.8%
Net Income
231
Net Margin
14.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
361
EBITDA Margin
23.0%

2020

12/31/2020

Revenue
1,368
Cost of Revenue
478
Gross Profit
890
Gross Margin
65.1%
Operating Income
325
Operating Margin
23.8%
Net Income
223
Net Margin
16.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
378
EBITDA Margin
27.7%